Topo
O site do Hospital Beatriz Ângelo usa cookies para assegurar uma experiência de utilização adequada e para conhecer o fluxo de visitas e suas características.
Ao navegar neste site está a consentir a utilização de cookies. Para mais informações consulte a Política de Cookies.
Serviço Nacional de Saúde

Hospital Beatriz Ângelo

Navegação Principal do site

Ensaios clínicos com recrutamento fechado


Ensaios clínicos na área da pneumologia:
  • TRIBUTE: A 52-week, Double Blind, Double dummy, Randomized, Multinational, Multicentre, 2-arm Parallel Group, active Controlled Clinical Trial of fixed combination of beclometasone dipropionate plus formoterol fumarate plus Glycopyrronium bromide administered via pMDI (CHF 5993) versus indacaterol/glycopyrronium (Ultibro®) via DPI in patients with Chronic Obstructive Pulmonary Disease.
Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001704-22/PT


Ensaios clínicos na área da Neurologia:
  • PROTEC: A Multicenter, Open-Label Study Evaluating the Effectiveness of Oral Tecfidera™ (Dimethyl Fumarate) on MS Disease Activity and Patient-Reported Outcomes in Subjects with Relapsing-Remitting Multiple Sclerosis in the Real World Setting


Ensaios clínicos na área do carcinoma da bexiga
  • GO29294: A phase III, open-label, multicenter, randomized study to investigate the efficacy and safety of MPDL3280A (anti-PD-L1 antibody) compared with chemotherapy in patients with locally advanced or metastatic urothelial bladder cancer after failure with platinum-containing chemotherapy.
Mais informação em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003231-19/PT


Ensaios clínicos na área do carcinoma mama
  •  FB-7 - A Phase II Randomized Clinical Trial Evaluating Neoadjuvant Therapy Regimens with Weekly Paclitaxel plus Neratinib or Trastuzumab or Neratinib and Trastuzumab Followed by Doxorubicin and Cyclophosphamide with Postoperative Trastuzumab in Women with Locally Advanced HER2-Positive Breast Cancer.
Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004391-35/PT
 

Ensaios clínicos na área da esclerose múltipla
  • RPC01-301: A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple sclerosis patients.
Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/PT


voltar
 
 
Luz Saúde, S.A., Sociedade Aberta © 2017